Technology & Science
Apr. 6, 2011
Biotechs Look Overseas to Launch Products
Pharmaceutical and medical device manufacturers are looking to foreign markets to launch new products, often before selling drugs and devices in the United States, because they can no longer predict regulatory outcomes here.
Daily Journal Staff Writer
Pharmaceutical and medical device manufacturers are looking to foreign markets to launch new products, often before selling drugs and devices in the U.S., because they can no longer predict regulatory outcomes here.
Lawyers are advising clients on overseas investments, regulations and patents while they go after approval from the U.S. Food and Drug Administration. And more companies, with encourageme...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In